CRC Research Update

  • RESEARCH

    KRAS Mutation Subtypes May Influence Response to Neoadjuvant Therapy in Rectal Cancer

    A meta-analysis investigated whether different KRAS mutation subtypes affect pathological complete response rates after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. The study examined KRAS mutations within and outside exon 2. (BJS Open)

  • SCREENING

    Study Examines Universal Tumor Screening for Lynch Syndrome in Japan

    A prospective study of 591 patients with stage II/III colorectal cancer in Japan aimed to clarify the clinical utility and cost-effectiveness of universal tumor screening using immunohistochemistry to identify Lynch syndrome, with implications for screening strategies in different populations. (International Journal of Clinical Oncology)

🔬 Under 50 Spotlight

Research relevant to early-onset and younger CRC patients

  • Early-Onset CRC Among Young Latino Men Linked to Structural Inequities

    An editorial co-authored by a Latino cancer survivor diagnosed at age 38 examines how molecular epidemiology and structural inequities converge in early-onset colorectal cancer among young Latino men, who face diagnostic delays, lower screening rates, and worse outcomes. (Cureus)

💙 Living with CRC

Survivorship, quality of life, and supportive care

  • Shared Decision-Making Framework for CRC Screening Choices

    A review emphasizes the importance of tailoring screening strategies to individual patient risk profiles and using shared decision-making to guide patients through screening choices based on age, family history, comorbidities, and psychosocial factors. (Clinical Colon and Rectal Surgery)

Research continues to advance our understanding of personalized treatment and early detection strategies. Stay informed and discuss new findings with your care team.